ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 445 filers reported holding ENCOMPASS HEALTH CORP in Q4 2018. The put-call ratio across all filers is 1.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $20,556,000 | +2.0% | 263,432 | +7.1% | 0.05% | -2.0% |
| Q1 2021 | $20,154,000 | -1.1% | 246,077 | -0.1% | 0.05% | -5.6% |
| Q4 2020 | $20,375,000 | +23.7% | 246,400 | -2.8% | 0.05% | +1.9% |
| Q3 2020 | $16,466,000 | +1.1% | 253,394 | -3.6% | 0.05% | -7.0% |
| Q2 2020 | $16,281,000 | -4.4% | 262,894 | -1.1% | 0.06% | -24.0% |
| Q1 2020 | $17,025,000 | -2.0% | 265,886 | +6.0% | 0.08% | +29.3% |
| Q4 2019 | $17,369,000 | -16.7% | 250,746 | -23.9% | 0.06% | -18.3% |
| Q3 2019 | $20,847,000 | -55.1% | 329,440 | -55.1% | 0.07% | -53.0% |
| Q2 2019 | $46,457,000 | -38.0% | 733,225 | -42.9% | 0.15% | -39.6% |
| Q1 2019 | $74,988,000 | +2.1% | 1,284,042 | +7.8% | 0.25% | -6.7% |
| Q4 2018 | $73,464,000 | -25.8% | 1,190,662 | -6.2% | 0.27% | -2.2% |
| Q3 2018 | $98,968,000 | -15.5% | 1,269,632 | -26.6% | 0.27% | -19.9% |
| Q2 2018 | $117,150,000 | +0.8% | 1,729,918 | -14.9% | 0.34% | -0.9% |
| Q1 2018 | $116,238,000 | – | 2,033,203 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |